BIOSENSE WEBSTER, INC.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1970-01-01
- Employees
- 1K
- Market Cap
- -
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study
- Conditions
- Heart DiseasesArrhythmiaAtrial Fibrillation
- Interventions
- Device: Radiofrequency Ablation
- First Posted Date
- 2008-07-23
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Biosense Webster, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT00721149
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸University of Rochester Medical Center, Rochester, New York, United States
🇺🇸Cleveland Clinic Foundation, Cleveland, Ohio, United States
A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Device: Radiofrequency ablation, antiarrhythmic drugsDrug: Amiodarone, flecainide, propafenone, quinidine, dofetilide, sotalol, cibenzoline, beta blocking and calcium channel blocking agents and antiarrhythmic drugsDevice: ThermoCool Radiofrequency Catheter
- First Posted Date
- 2007-10-08
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Biosense Webster, Inc.
- Target Recruit Count
- 112
- Registration Number
- NCT00540787
- Locations
- 🇫🇷
Hôpital Haut Lèvêque, Pessac, Paris, France
🇨🇭Hopital Cantonal de Geneve, Geneva, Switzerland
🇫🇷Hopital Lariboisiere, Paris, France
Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study
- Conditions
- Cardiac Arrhythmias
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Biosense Webster, Inc.
- Registration Number
- NCT00449085
Catheter Evaluation for Endocardial Ablation in Patients With Ventricular Tachycardia
- Conditions
- Ventricular Tachycardia
- Interventions
- Device: NAVISTAR® THERMOCOOL® Catheter
- First Posted Date
- 2006-12-18
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Biosense Webster, Inc.
- Target Recruit Count
- 249
- Registration Number
- NCT00412607
- Locations
- 🇺🇸
Good Samaritan Hospital, Los Angeles, California, United States
🇺🇸Stanford University School of Medicine, Stanford, California, United States
🇺🇸Arizona Arrhythmia Consultants, Scottsdale, Arizona, United States
Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter
- Conditions
- Atrial Flutter
- Interventions
- Device: RF energy delivery for treatment of Typical Atrial flutter
- First Posted Date
- 2006-04-27
- Last Posted Date
- 2012-03-05
- Lead Sponsor
- Biosense Webster, Inc.
- Target Recruit Count
- 291
- Registration Number
- NCT00318565
- Locations
- 🇺🇸
Good Samaritan Hospital, Los Angeles, California, United States
🇺🇸Memorial Regional Hospital, Hollywood, Florida, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
- Conditions
- Heart DiseasesArrhythmiaAtrial Fibrillation
- Interventions
- Device: NAVISTAR® THERMOCOOL® CatheterDrug: Antiarrhythmic drug
- First Posted Date
- 2005-06-30
- Last Posted Date
- 2017-10-24
- Lead Sponsor
- Biosense Webster, Inc.
- Target Recruit Count
- 167
- Registration Number
- NCT00116428
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
🇺🇸Marin General Hospital, Greenbrae, California, United States
🇺🇸St. Lukes Roosevelt Hospital, New York, New York, United States